Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0000899243-21-027628

Options or other derivatives

  • Director acquired 2,225 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Ros Matthew Director 2021-07-01 Grant or award · Stock Option (Right to Buy) +2,225 $4.78 $10,625 2,225 D
Loading xslF345X03/doc4.xml…